MESO

Mesoblast Limited American Depositary Shares (MESO)

About Mesoblast Limited American Depositary Shares (MESO)

Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.

Details

Daily high

$15.61

Daily low

$13.70

Price at open

$14.96

52 Week High

$19.15

52 Week Low

$1.61

Market cap

1.7B

Dividend yield

0.00%

Volume

1.9M

Avg. volume

569,194

P/E ratio

-16.45

Mesoblast Limited American Depositary Shares News